Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Tanshinone IIA alleviates pulmonary fibrosis by modulating glutamine metabolic reprogramming based on [U-(13)C(5)]-glutamine metabolic flux analysis
J Biomed Biotechnol 2011:609813 Lange S, Rocha-Ferreira E, Thei L, Mawjee P, Bennett K, Thompson PR, Subramanian V, Nicholas AP, Peebles D, Hristova M et al (2014) Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates
As a proof-of-concept, first-in-patient trial in people with type 2 diabetes, the inclusion/exclusion criteria were more restrictive and therefore the results may not be generalisable to the entire insulin-naive type 2 diabetes population
"The blood-brain barrier and glutamate"
